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Lamins are the evolutionary progenitors of cytoskeletal
intermediate filament (IF) proteins. In mammalian cells, IF
proteins are almost ubiquitously expressed with approxi-
mately 60 different members known to date (Fuchs and
Weber, 1994).
Lamins are characterized by an additional heptad repeat-
motif of 42 amino acids in the rod domain. By their a-helical
rod domain, lamins form coiled coil dimers that further po-
lymerize in a head-to-tail fashion to form the lamina, a net-
work lining the nucleoplasmatic side of the inner nuclear
membrane (Aebi et al, 1986). Lamins are not only present in
the nuclear lamina but are also found in the nucleoplasm,
being part of intranuclear tubes and present as scaffold
proteins. Here, they are thought to play an important role in
maintenance of the structural integrity of the nucleus, in
DNA replication, in transcription repression, and in apopto-
sis (for a review see Fuchs and Weber, 1994; Broers et al,
1997; Wilson et al, 2001; Hutchison and Worman, 2004).
Within the IF gene family, two main types of lamins are
currently distinguished, the type A and the type B lamins. B-
type lamins, represented by lamin B1, B2, and B3, are the
initial building blocks of the nuclear lamina and are ubi-
quitously expressed in all mammalian cells. By contrast,
expression of A-type lamins is almost undetectable in cells
with a low degree of differentiation and/or in highly prolif-
erating cells. By means of alternative splicing, the lamin A/C
(LMNA) gene encodes at least four different A-type lamin
protein members, lamin A, lamin AD10, lamin C, and lamin
C2 (Broers et al, 1997; Hutchinson and Worman, 2004).
Mutations in the LMNA gene are associated with a broad
spectrum of disorders that are collectively called lamino-
pathies. The associated phenotypes include Emery–Dreifus
muscular dystrophy, limb-girdle muscular dystrophy, dilated
cardiomyopathy with conduction defect, Charcot–Marie-
Tooth disease, Dunnigan-type familial partial lipodystrophy,
mandibulo-acral dysplasia and Hutchinson–Gilford progeria
(for a review see Broers et al, 2004; Hutchinson and Wor-
man, 2004). Why so many different phenotypes can be as-
sociated with mutations in a single gene is presently poorly
understood.
It is clear now that an intricate series of enzymatic mod-
ifications is required for the production of a normal lamin A.
Prelamin A is farnesylated on its C-terminus and subse-
quently hydrolyzed. The zinc metalloprotease ZMPSTE24 is
required for the final step. Its lack is therefore associated
with the presence of abnormal amounts of (farnesylated)
prelamin A in the nucleus, which is thought to be toxic to the
cell (Kilic et al, 1999). Absence of ZMPSTE24 apparently
does not affect the alternative splicing product, lamin C.
Thus, it is not surprising that homozygous mutations in the
ZMPSTE24 gene were found to cause laminopathies (Agar-
wal et al, 2003; Navarro et al, 2004).
What is surprising, however, is that all ZMPSTE24 gene
mutations in humans and mice are associated with pro-
geroid disorders. Initally, mandibulo-acral dysplasia (MAD),
a disorder that is very similar to the more well-known
Hutchinson–Gilford progeria syndrome (HGPS), was the
only associated disease. Homozygous and compound het-
erozygous mutations in ZMPSTE24 were found in patients
with typical MAD (Agarwal et al, 2003).
HGPS, on the other hand, is so far apparently exclusively
associated with heterozygous and compound heterozygous
mutations in LMNA (for a review see Pollex and Hegele,
2004). The heterozygous mutation affects splicing of the
LMNA gene so that a truncated prelamin A lacking 50 C-
terminal amino acids is generated that cannot be pro-
cessed. As it still contains the CAAX box, it is farnesylated.
A toxic action of this truncated protein was postulated to
account for the apparent dominant inheritance of HGPS
(Fong et al, 2004).
Restrictive dermopathy (RD), also referred to as tight skin
contracture syndrome, is a rare disorder that can be con-
sidered as a lethal form of HGPS. It is characterized by
intrauterine growth retardation, tight and rigid skin with ero-
sions, prominent superficial vasculature and epidermal
hyperkeratosis, characteristic facial features (small mouth,
small pinched nose and micrognathia), sparse to absent
eyelashes and eyebrows, mineralization defects of the skull,
thin dysplastic clavicles, pulmonary hypoplasia, multiple
joint contractures, and an early neonatal lethal course. In-
terestingly, Navarro et al (2004) recently reported that RD
was associated with heterozygous mutations in ZMPSTE24
and quite convincingly demonstrated defective lamin
processing in their patients. Digenic inheritance was pos-
tulated as a possible explanation for the fact that het-
erozygous parents were healthy, whereas their equally
heterozygous children had RD and defective lamin A
processing, but Navarro et al were not able to detect
homozygous or compound heterozygous mutations in
ZMPSTE24, nor were they and others able to demonstrate
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digenic inheritance (Navarro et al, 2004; own data, not yet
published).
Although this problem has now apparently been solved,
other questions immediately arise. In this issue of the JID,
Moulson et al report their finding of homozygous and com-
pound heterozygous mutations in the ZMPSTE24 gene in
RD (Moulson et al, this issue). They further state that it is
quite likely that compound heterozygous mutations were
missed in the report by Navarro et al. Moulson et al clearly
demonstrate defective lamin A pre-processing and nuclear
abnormalities as the characteristic hallmarks found in all
other laminopathies, thus providing the first definitive proof
that RD is a laminopathy. Furthermore, they confirm reces-
sive inheritance of RD, which is invaluable for genetic coun-
seling but also for our understanding of the pathogenesis of
RD and related disorders.
An essential finding in their report deserves special at-
tention because it may cast some doubt on the supposition
that prelamin A is toxic. The nuclear localization of emerin,
an inner nuclear membrane protein, is normal in RD fibro-
blasts. It is probably kept in its normal position by prelamin
A, that is incorporated into the nuclear lamina and can ap-
parently function normally as far as its binding to emerin is
concerned. Although this does not prove that prelamin A is
not toxic, it does, however, raise significant doubts regard-
ing its supposed toxicity. Thus, the current explanation for
the apparently dominant nature of mutations in HGPS may
not be true. Instead, we think that it is far more likely that,
like MAD and RD, HGPS is recessive and that the mutations
in the other allele have simply not been detected.
In support of this notion, a recent report by Capanni et al
(2005) shows that increased amounts of prelamin A are
present not only in HGPS, but also in MAD and familial
partial lipodystrophy of the Dunnigan type, another lam-
inopathy. If prelamin A were toxic, one would expect more
uniformity within this phenotypic spectrum. Rather than be-
ing toxic, however, prelamin A may bind the SREBP1 pro-
tein and limit its translocation to the nuclear interior, thereby
interfering with fat metabolism by lowering PPAR-g expres-
sion. The lipodystrophy that is common to all of these phe-
notypes may well result from this phenomenon. The
progeroid phenotype of MAD, RD, and HGPS, on the oth-
er hand, seems to be the consequence of the absence of a
functional lamin A network per se, as the mutations causing
Dunnigan-type lipodystrophy and the various muscular dys-
trophies do not affect lamin structure (Krimm et al, 2002).
Still, a very significant question remains. What causes the
phenotypic variation within the group of the progeroid lami-
nopathies? As mutations in genes known to interact with
lamin A have so far not been found in any of these disor-
ders, the most plausible explanation for the observed
phenotypic variability might be to postulate the putative
presence of other hitherto undetected genetic defects in-
teracting with lamin deficiency. Thus, the detection of novel
genes involved in laminopathies and the functional charac-
terization of their protein products will be one of the most
important missions for researchers in the near future.
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